EU · EudraLex Vol.4
EU GMP Annex 1 8.11
8. Production and Specific Technologies › Aseptic preparation and processing
조항 원문
For sterile products where the final formulation cannot be filtered, the following should be considered:
i. All product and component contact equipment should be sterilised prior to use.
ii. All raw materials or intermediates should be sterilised and aseptically added.
iii. Bulk solutions or intermediates should be sterilised.
본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.
출처: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · 수집일 2026-11-15